Post
The Wall Street Journal
wsj.com
did:plc:i3fhjvvkbmirhyu4aeihhrnv
The U.K.’s health regulator approved a higher dose of Novo Nordisk’s Wegovy weight-loss drug applicable to patients with a body mass index of at least 30. on.wsj.com/4sGKpXG
https://on.wsj.com/4sGKpXG
2026-01-16T14:26:44.336Z